OBJECTIVE: To test whether "venue-based testing" could identify human immunodeficiency virus (HIV) infection in US youth, 12 to 24 years of age, who were otherwise not aware of their infection. Racial and ethnic minority women and men who have sex with men (WSM and MSM) compose the majority of new HIV cases among adolescents and young adults. DESIGN: Cross-sectional study. SETTING: Selected venues in communities surrounding the 15 Adolescent Trials Network for HIV/AIDS Interventions (ATN) clinical sites over a 3-month period. PARTICIPANTS: At each venue, ATN sites recruited 20 to 30 English- or Spanish-speaking at-risk youth (12 to 24 years of age), resulting in a total of 1217 study participants, including 611 MSM and 606 WSM. Intervention Venue-based HIV testing with 2 components: an anonymous audio computer-assisted self-administered interview and an anonymous HIV antibody assay. MAIN OUTCOME MEASURE: The prevalence of HIV infection in MSM and WSM. RESULTS: The prevalence of HIV infection in MSM and WSM was 15.3% and 0.3%, respectively. Sixty percent of the MSM and 100% of the WSM claimed to not know of their infection. CONCLUSION: Venue-based testing may be an important strategy to identify HIV-infected younger MSM; however, other strategies are needed for WSM.
OBJECTIVE: To test whether "venue-based testing" could identify human immunodeficiency virus (HIV) infection in US youth, 12 to 24 years of age, who were otherwise not aware of their infection. Racial and ethnic minority women and men who have sex with men (WSM and MSM) compose the majority of new HIV cases among adolescents and young adults. DESIGN: Cross-sectional study. SETTING: Selected venues in communities surrounding the 15 Adolescent Trials Network for HIV/AIDS Interventions (ATN) clinical sites over a 3-month period. PARTICIPANTS: At each venue, ATN sites recruited 20 to 30 English- or Spanish-speaking at-risk youth (12 to 24 years of age), resulting in a total of 1217 study participants, including 611 MSM and 606 WSM. Intervention Venue-based HIV testing with 2 components: an anonymous audio computer-assisted self-administered interview and an anonymous HIV antibody assay. MAIN OUTCOME MEASURE: The prevalence of HIV infection in MSM and WSM. RESULTS: The prevalence of HIV infection in MSM and WSM was 15.3% and 0.3%, respectively. Sixty percent of the MSM and 100% of the WSM claimed to not know of their infection. CONCLUSION: Venue-based testing may be an important strategy to identify HIV-infected younger MSM; however, other strategies are needed for WSM.
Authors: Martina Morris; Mark S Handcock; William C Miller; Carol A Ford; John L Schmitz; Marcia M Hobbs; Myron S Cohen; Kathleen M Harris; J Richard Udry Journal: Am J Public Health Date: 2006-05-02 Impact factor: 9.308
Authors: Mauri A Ziff; Gary W Harper; Kate S Chutuape; Bethany Griffin Deeds; Donna Futterman; Vincent T Francisco; Larry R Muenz; Jonathan M Ellen Journal: J Urban Health Date: 2006-05 Impact factor: 3.671
Authors: L A Valleroy; D A MacKellar; J M Karon; D H Rosen; W McFarland; D A Shehan; S R Stoyanoff; M LaLota; D D Celentano; B A Koblin; H Thiede; M H Katz; L V Torian; R S Janssen Journal: JAMA Date: 2000-07-12 Impact factor: 56.272
Authors: Lorena Espinoza; H Irene Hall; Felicia Hardnett; Richard M Selik; Qiang Ling; Lisa M Lee Journal: Am J Public Health Date: 2006-11-30 Impact factor: 9.308
Authors: Lorrie Gavin; Andrea P MacKay; Kathryn Brown; Sara Harrier; Stephanie J Ventura; Laura Kann; Maria Rangel; Stuart Berman; Patricia Dittus; Nicole Liddon; Lauri Markowitz; Maya Sternberg; Hillard Weinstock; Corinne David-Ferdon; George Ryan Journal: MMWR Surveill Summ Date: 2009-07-17
Authors: Kate S Chutuape; Mauri Ziff; Colette Auerswald; Marné Castillo; Antionette McFadden; Jonathan Ellen Journal: J Urban Health Date: 2008-10-30 Impact factor: 3.671
Authors: Diane M Straub; Renata Arrington-Sanders; D Robert Harris; Nancy Willard; Bill Kapogiannis; Patricia Emmanuel; Donna Futterman; Jonathan M Ellen Journal: Sex Transm Dis Date: 2011-08 Impact factor: 2.830
Authors: Yvette Calderon; Ethan Cowan; John Y Rhee; Christopher Brusalis; Jason Leider Journal: AIDS Patient Care STDS Date: 2013-07-24 Impact factor: 5.078
Authors: Sybil G Hosek; Bret Rudy; Raphael Landovitz; Bill Kapogiannis; George Siberry; Brandy Rutledge; Nancy Liu; Jennifer Brothers; Kathleen Mulligan; Gregory Zimet; Michelle Lally; Kenneth H Mayer; Peter Anderson; Jennifer Kiser; James F Rooney; Craig M Wilson Journal: J Acquir Immune Defic Syndr Date: 2017-01-01 Impact factor: 3.731
Authors: Peter Freeman; Bendu C Walker; D Robert Harris; Robert Garofalo; Nancy Willard; Jonathan M Ellen Journal: Arch Pediatr Adolesc Med Date: 2011-08
Authors: Cherrie B Boyer; Lauren Greenberg; Kate Chutuape; Bendu Walker; Dina Monte; Jennifer Kirk; Jonathan M Ellen Journal: J Community Health Date: 2017-02
Authors: Russell B Toomey; Virginia W Huynh; Samantha K Jones; Sophia Lee; Michelle Revels-Macalinao Journal: J Gay Lesbian Ment Health Date: 2016-07-27
Authors: Robin Lin Miller; Cherrie B Boyer; Danielle Chiaramonte; Peter Lindeman; Kate Chutuape; Bendu Cooper-Walker; Bill G Kapogiannis; Craig M Wilson; J Dennis Fortenberry Journal: JAMA Pediatr Date: 2017-06-01 Impact factor: 16.193
Authors: Cherrie B Boyer; Lisa Hightow-Weidman; James Bethel; Su X Li; Lisa Henry-Reid; Donna Futterman; Donna Maturo; Diane M Straub; Kourtney Howell; Shirleta Reid; Jaime Lowe; Bill G Kapogiannis; Jonathan M Ellen Journal: JAMA Pediatr Date: 2013-03-01 Impact factor: 16.193
Authors: Cherrie B Boyer; Grisel M Robles-Schrader; Su X Li; Robin L Miller; James Korelitz; Georgine N Price; Carmen M Rivera Torres; Kate S Chutuape; Stephanie J Stines; Diane M Straub; Ligia Peralta; Irma Febo; Lisa Hightow-Weidman; René Gonin; Bill G Kapogiannis; Jonathan M Ellen Journal: J Adolesc Health Date: 2014-09-13 Impact factor: 5.012